Document is current
Any future updates will be listed below
-
Authors
Zehentner, Sofie
Mistlberger-Reiner, Agnes
Pirkwieser, Philip
Orth, Noreen
Boger, Valerie
Kahlenberg, Kristin
Kreißl, Johanna
Grimm, Christoph
Ley, Jakob Peter
Somoza, Veronika
-
Funding
Funding for this research was provided by:
Technische Universität München
- License Information
-
More Information
Article History
Received: 26 August 2025
Accepted: 7 January 2026
First Online: 20 January 2026
Declarations
:
: C.G. has the following outside interests: consultant (Abbvie, AstraZeneca, Celgene, Clovis, Eisai, GSK, MSD, PharmaMar, Roche, Vifor Pharma, Sandoz), speaker (Abbvie, Amgen, AstraZeneca, Eisai, GSK, MSD, PharmaMar, Roche, Sandoz), direct research funding (AstraZeneca, Meda Pharma, Roche Diagnostics), travel/meeting support (AstraZeneca, GSK, MSD, PharmaMar, Roche, Roche Diagnostics). None of these interests of C.G. had any influence on the work presented here. All other authors declare no conflicts of interest. The funder played no role in the design of the study, in the collection, analysis or interpretation of the data, in the writing of the manuscript or in the decision to publish the results.
